Smartphone apps for cancer: A content analysis of the digital health marketplace.
Cancer
digital health
information resources
mobile applications
oncology
quality
Journal
Digital health
ISSN: 2055-2076
Titre abrégé: Digit Health
Pays: United States
ID NLM: 101690863
Informations de publication
Date de publication:
Historique:
received:
24
05
2019
accepted:
14
01
2020
entrez:
29
2
2020
pubmed:
29
2
2020
medline:
29
2
2020
Statut:
epublish
Résumé
The purpose of this study was to examine the state of smartphone applications for cancer intended for the general public with a focus on interactive features, content sources, and application developer affiliations. The level of health provider involvement in screening or appraising application content was also assessed. A total of 123 apps were identified for analysis from two major mobile application marketplaces (Apple iTunes = 40; Google Play = 83). Application characteristics were collected, analyzed, and reported. These included the mobile platform, cost, application developer affiliation, date of last update, purpose of application, content sources, and interactive features. In the study sample, 50% of the applications focused on general information for cancer (62/123). Next, this was followed by applications for breast cancer (15%, 19/123) and skin cancer (7%, 8/123). Only 10% of application descriptions (12/123) identified sources for application content. Interactive features included the ability to monitor symptoms, side effects, treatments, and chronic pain (20%, 25/123). Only 3% of the applications (4/123) stated content had been evaluated by health providers. This study contributes an updated analysis of applications for cancer available in the digital health marketplace. The findings have implications for information quality and supportive resources for cancer care. More transparent information about content sources, organizational affiliations, and level of health provider oversight in screening application content is warranted. Recommendations for improving the quality of cancer applications are also offered.
Identifiants
pubmed: 32110428
doi: 10.1177/2055207620905413
pii: 10.1177_2055207620905413
pmc: PMC7016299
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2055207620905413Informations de copyright
© The Author(s) 2020.
Références
JMIR Mhealth Uhealth. 2017 Dec 04;5(12):e187
pubmed: 29203459
J Health Commun. 2017 Dec;22(12):999-1006
pubmed: 29206573
JMIR Mhealth Uhealth. 2018 Mar 16;6(3):e62
pubmed: 29549075
Farm Hosp. 2016 Jan 01;40(1):25-35
pubmed: 26882831
J Med Internet Res. 2011 Jul 14;13(3):e49
pubmed: 21752785
Br J Dermatol. 2015 Jun;172(6):1507-1518
pubmed: 25600815
Evid Based Ment Health. 2017 Aug;20(3):65-70
pubmed: 28666986
J Med Internet Res. 2013 Apr 18;15(4):e86
pubmed: 23598614
Transl Androl Urol. 2018 Feb;7(1):170-181
pubmed: 29594031
JMIR Mhealth Uhealth. 2017 Mar 13;5(3):e20
pubmed: 28288954
Pediatr Blood Cancer. 2018 Nov;65(11):e27278
pubmed: 29943893
J Med Internet Res. 2018 Dec 21;20(12):e11439
pubmed: 30578201
Ann Oncol. 2018 Jan 1;29(1):30-35
pubmed: 29140430
J Med Internet Res. 2013 Dec 23;15(12):e287
pubmed: 24366061
Patient Educ Couns. 2017 Jan;100(1):25-29
pubmed: 27473639
Dermatol Clin. 2017 Oct;35(4):551-557
pubmed: 28886812
J Med Internet Res. 2015 Nov 27;17(11):e270
pubmed: 26614438
J Cancer Res Clin Oncol. 2018 Jan;144(1):173-181
pubmed: 29052039